PR Newswire updates

09.16
2026
Introducing Fotor Agent: Create Fully Editable AE-Quality Motion Graphics and Long-Form Videos
09.16
2026
ugee Unveils ArtPlay Pad: EMR-Powered Creative Tablet Turns Children's 2D Sketches Into Physical 3D Works
09.15
2026
Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients

A RARE OPPORTUNITY TO OWN A HISTORIC PROPERTY IN NEW YORK'S VILLAGE
November 17, 2024

Introducing Fotor Agent: Create Fully Editable AE-Quality Motion Graphics and Long-Form Videos

Fotor Agent, ranked No. 1 Product of the Day on Product Hunt,…

ugee Unveils ArtPlay Pad: EMR-Powered Creative Tablet Turns Children's 2D Sketches Into Physical 3D Works

ugee Unveils ArtPlay Pad: EMR-Powered Creative Tablet Turns Children's 2D Sketches Into Physical 3D Works

Designed for the way today’s youth create—anytime, anywhere, across any medium…

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients

The fifteen-month dataset represents the final analysis from the Phase 1/2 study…

Minesto presents today at Aktiedagen i Stockholm

GOTHENBURG, Sweden, Sept. 16, 2026 /PRNewswire/ — Minesto’s CEO Dr Martin…